Scheinberg DA - Search Results

1

Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.

Dao T, Yan S, Veomett N, Pankov D, Zhou L, Korontsvit T, Scott A, Whitten J, Maslak P, Casey E, Tan T, Liu H, Zakhaleva V, Curcio M, Doubrovina E, O'Reilly RJ, Liu C, Scheinberg DA. Dao T, et al. Among authors: scheinberg da. Sci Transl Med. 2013 Mar 13;5(176):176ra33. doi: 10.1126/scitranslmed.3005661. Sci Transl Med. 2013. PMID: 23486779 Free PMC article.

2

Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.

Nikula TK, Bocchia M, Curcio MJ, Sgouros G, Ma Y, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Mol Immunol. 1995 Aug;32(12):865-72. doi: 10.1016/0161-5890(95)00052-g. Mol Immunol. 1995. PMID: 7565813

3

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies.

Nikula TK, Curcio MJ, Brechbiel MW, Gansow OA, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Nucl Med Biol. 1995 Apr;22(3):387-90. doi: 10.1016/0969-8051(94)00126-5. Nucl Med Biol. 1995. PMID: 7627155

4

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.

Jurcic JG, Caron PC, Miller WH Jr, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP Jr, Scheinberg DA. Jurcic JG, et al. Among authors: scheinberg da. Leukemia. 1995 Feb;9(2):244-8. Leukemia. 1995. PMID: 7869759

5

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.

Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr. Vahdat L, et al. Among authors: scheinberg da. Blood. 1994 Dec 1;84(11):3843-9. Blood. 1994. PMID: 7949141 Free article. Review.

6

IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells.

Czuczman MS, Garin-Chesa P, Lemoli RM, Scheinberg DA. Czuczman MS, et al. Among authors: scheinberg da. Cancer Immunol Immunother. 1993 Jun;36(6):387-96. doi: 10.1007/BF01742255. Cancer Immunol Immunother. 1993. PMID: 8500111 Free PMC article.

7

Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.

Maslak PG, Weiss MA, Berman E, Yao TJ, Tyson D, Golde DW, Scheinberg DA. Maslak PG, et al. Among authors: scheinberg da. Leukemia. 1996 Jan;10(1):32-9. Leukemia. 1996. PMID: 8558934 Clinical Trial.

8

Specific human cellular immunity to bcr-abl oncogene-derived peptides.

Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Bocchia M, et al. Among authors: scheinberg da. Blood. 1996 May 1;87(9):3587-92. Blood. 1996. PMID: 8611681 Free article.

9

The multidrug resistance phenotype confers immunological resistance.

Weisburg JH, Curcio M, Caron PC, Raghu G, Mechetner EB, Roepe PD, Scheinberg DA. Weisburg JH, et al. Among authors: scheinberg da. J Exp Med. 1996 Jun 1;183(6):2699-704. doi: 10.1084/jem.183.6.2699. J Exp Med. 1996. PMID: 8676093 Free PMC article.

10

Bone marrow dosimetry: regional variability of marrow-localizing antibody.

Sgouros G, Jureidini IM, Scott AM, Graham MC, Larson SM, Scheinberg DA. Sgouros G, et al. Among authors: scheinberg da. J Nucl Med. 1996 Apr;37(4):695-8. J Nucl Med. 1996. PMID: 8691269 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters